- Lobbying
- institute AND for AND gene AND therapies
Lobbying Arrangements Results for 'Institute For Gene Therapies'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to regulatory and reimbursement policies for innovative gene therapies. H.R.7389 - MVP Act. |
Institute for Gene Therapies
|
Thorn Run Partners | |||
Details Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022 Issues related to the regulation of gene therapies; newborn screening; FDA appropriations |
Institute for Gene Therapies
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to the development of gene therapies for rare diseases |
Spark Therapeutics, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutic... |
Novartis
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Antibiotic Use in Livestock ---H.R.4012: To repeal the guidance titled "CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntar... |
Biotechnology Innovation Organization
|
in-house lobbying | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
Pharmaceutical Research and Manufacturers of America
|
in-house lobbying |